Virtu Financial’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Virtu Financial’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,905	Closed	-$24K	–	2156
2026 Q1	$24K	Buy	+32,905	New	+$150K	﹤0.01%	1375
2025 Q2	–	Sell	-565	Closed	-$11K	–	1975
2025 Q1	$11K	Buy	+565	New	+$17.8K	﹤0.01%	1172
2024 Q4	–	Sell	-713	Closed	-$21K	–	1987
2024 Q3	$21K	Buy	+713	New	+$15.8K	﹤0.01%	1124
2024 Q1	–	Sell	-762	Closed	-$78K	–	1999
2023 Q4	$78K	Buy	+762	New	+$68.4K	0.01%	1080
2023 Q3	–	Sell	-922	Closed	-$108K	–	1807
2023 Q2	$108K	Buy	+922	New	+$117K	0.01%	1026
2022 Q4	–	Sell	-2,306	Closed	-$73K	–	2070
2022 Q3	$73K	Buy	+2,306	New	+$63.7K	0.01%	1139

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Virtu Financial's RVPH Position: Q2 2026 in Review

Virtu Financial sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 32,905 shares — an estimated $24K sold.

Virtu Financial first reported a position in RVPH in Q3 2022 and held it in 6 quarters. The position peaked at $108K in Q2 2023. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Virtu Financial reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 32,905 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $24K.
Virtu Financial first reported a position in REVIVA PHARMA HLDGS INC in Q3 2022 and held it in 6 quarters.
Virtu Financial's REVIVA PHARMA HLDGS INC position peaked at $108K in Q2 2023.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.